Related Articles
Impact of copy number variant and single nucleotide polymorphism of the programmed death‑ligand 1 gene, programmed death‑ligand 1 protein expression and therapy regimens on overall survival in a large group of Caucasian patients with non‑small cell lung carcinoma
Dynamic contrast‑enhanced MRI as a predictor of programmed death ligand‑1 expression in patients with oral squamous cell carcinoma
Impact of the immune molecular profile of the tumor microenvironment on the prognosis of NSCLC
Detection of PD‑L1 expression and epithelial‑mesenchymal transition of circulating tumor cells in non‑small cell lung cancer
Efficacy and safety of adjuvant therapy with PD‑1/PD‑L1 inhibitors in cancer